HEALTHCARE
Trump administration to create board to oversee NIH grant funding
President Donald Trump is reportedly preparing an executive order to create a new board that can approve or veto National Institutes of Health grants, a change that would give political appointees more direct control over which medical research projects get federal funding.
President Donald Trump is reportedly preparing an executive order to create a new board that can approve or veto National Institutes of Health grants, a change that would give political appointees more direct control over which medical research projects get federal funding.
Corroboration
LowMedHigh
Confirmed by 13+ sources.
What This is
- Trump has directed White House budget director Russell Vought to draft an executive order creating a board to decide which NIH research grants are funded.
- The board would reportedly include political appointees such as Vought and NIH director Jay Bhattacharya, and would require unanimous approval of grant awards.
- The plan would shift power away from NIH’s usual system, where outside scientific experts review proposals and score them on merit.
- NIH has said existing grants would not be rescinded, even as internal debate continues about additional review of NIH funding decisions.
- Researchers have filed a federal class-action lawsuit alleging NIH used a 235-term keyword list to flag, renegotiate, or terminate grants tied to topics like equity, gender identity, and climate change.
- One example cited in coverage is the early termination of an Alzheimer’s study in Pittsburgh involving about 600 mostly Black, low-income participants, which researchers say could delay analysis and diagnoses.
Why This Matters
- How NIH chooses grants shapes what diseases, communities, and treatments get studied first.
- Greater White House control would blur the line between scientific judgment and political power in federal research spending.
- Keyword-based screening raises basic free-speech questions about whether the government can punish research topics it dislikes.
- Abrupt grant changes can waste years of work and disrupt studies that rely on steady funding and long-term patient follow-up.




